Publications by authors named "Patrick Caubel"

Claim this Profile
A
Assessing knowledge, attitudes, and practices and demand-side interventions for combating substandard and falsified medicines: a scoping review.
Eishita Pal, Lubna Merchant, Alain K Koffi, Reema Mehta, Jean Christophe Rusatira, Patrick Caubel

J Pharm Policy Pract· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges and Innovations in Pharmacovigilance and Signal Management During the COVID-19 Pandemic: An Industry Perspective.
Maria Maddalena Lino, Susan Mather, Marianna Trani, Yan Chen, Patrick Caubel

Vaccines (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Retrospective Case Series Analysis of Pregnancy and COVID-19 Based on a Global Postmarketing COVID-19 Surveillance Program.
Elena Beyzarov, Yan Chen, Patrick Caubel

Clin Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reporting of COVID-19 Reinfection and Potential Role of Immunosuppressant/Immunomodulating Agents: A Cross-Sectional Observational Analysis Based on a Spontaneous Reporting Database.
Elena Beyzarov, Yan Chen, Patrick Caubel

Clin Drug Investig· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the COVID-19 Pandemic on Pharmacovigilance Strategy, Systems, and Processes of Large, Medium, and Small Companies: An Industry Survey.
Paul Beninger, Patrick Caubel, Latika Sharma, Geo Pajovich, Pete Boyd

Clin Ther· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nirmatrelvir-Ritonavir and Viral Load Rebound in Covid-19.
Annaliesa S Anderson, Patrick Caubel, James M Rusnak,

N Engl J Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Safety Database Summary of COVID-19-Related Drug Utilization-Safety Surveillance: A Sponsor's Perspective.
Elena Beyzarov, Yan Chen, Rob Julg, Karen Naim, Jigna Shah, Patrick Caubel

Drug Saf· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial designs using real-world data: The changing landscape of the regulatory approval process.
Elodie Baumfeld Andre, Robert Reynolds, Patrick Caubel, Laurent Azoulay, Nancy A Dreyer

Pharmacoepidemiol Drug Saf· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to "Pharmacovigilance 2030: Invited Commentary for the January 2020 'Futures' Edition".
Manfred Hauben, William W Gregory, Patrick Caubel

Clin Pharmacol Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Adverse Drug Reaction Case Safety Practices in Large Biopharmaceutical Organizations from 2007 to 2017: An Industry Survey.
Stella Stergiopoulos, Moritz Fehrle, Patrick Caubel, Louise Tan, Louise Jebson

Pharmaceut Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Drug Reaction Case Safety Practices in Large Biopharmaceutical Organizations from 2007 to 2017: An Industry Survey.
Stella Stergiopoulos, Mortiz Fehrle, Patrick Caubel, Louise Tan, Louise Jebson

Pharmaceut Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovation in Pharmacovigilance: Use of Artificial Intelligence in Adverse Event Case Processing.
Juergen Schmider, Krishan Kumar, Chantal LaForest, Brian Swankoski, Karen Naim, Patrick M Caubel

Clin Pharmacol Ther· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deconstructing the Pharmacovigilance Hype Cycle.
Manfred Hauben, Robert Reynolds, Patrick Caubel

Clin Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The hope, hype and reality of Big Data for pharmacovigilance.
Andrew Bate, Robert F Reynolds, Patrick Caubel

Ther Adv Drug Saf· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of New Signal Detection Methods for Web Query Log Data Compared to Signal Detection Algorithms Used With FAERS.
Susan Colilla, Elad Yom Tov, Ling Zhang, Marie-Laure Kurzinger, Stephanie Tcherny-Lessenot, Patrick Caubel

Drug Saf· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Facial nerve palsy including Bell's palsy: Case definitions and guidelines for collection, analysis, and presentation of immunisation safety data.
Barbara Rath, Jane F Gidudu, Helen Anyoti, Brigid Bollweg, Patrick Caubel

Vaccine· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of dronedarone utilization using US claims databases.
Jasmanda Wu, Jane Thammakhoune, Wanju Dai, Andrew Koren, Stephanie Tcherny-Lessenot, Patrick Caubel

Clin Ther· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Cardiovascular Events, Stroke, Congestive Heart Failure, Interstitial Lung Disease, and Acute Liver Injury: Dronedarone versus Amiodarone and Other Antiarrhythmics.
Shujun Gao, Wanju Dai, Ling Zhang, Juhaeri Juhaeri, Yunxun Wang, Patrick Caubel

J Atr Fibrillation· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amenorrhea due to partial uterine necrosis after uterine artery embolization for control of refractory postpartum hemorrhage.
Yvon Chitrit, Sylvie Zafy, Jean P Pelage, Olivier Ledref, Rames Khoury, Patrick Caubel

Eur J Obstet Gynecol Reprod Biol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
Stefan Arrenbrecht, Patrick Caubel, Patrick Garnero, Dieter Felsenberg

Maturitas· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feto-maternal alloimmune thrombocytopenia due to HPA-5b incompatibility: a case report.
Rafael J M Herrero, Yvon Chitrit, Patrick Caubel, Daniel Lusina

Eur J Obstet Gynecol Reprod Biol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Norelgestromin as selective estrogen enzyme modulator in human breast cancer cell lines. Effect on sulfatase activity in comparison to medroxyprogesterone acetate.
Jorge R Pasqualini, Patrick Caubel, Andrew J Friedman, Jean-Claude Philippe, Gérard Samuel Chetrite

J Steroid Biochem Mol Biol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermittent progestin administration as part of hormone replacement therapy: long-term comparison between estradiol 1 mg combined with intermittent norgestimate and estradiol 2 mg combined with constant norethisterone acetate.
Olavi Ylikorkala, Torsten Wahlström, Patrick Caubel, Rosanne Lane

Acta Obstet Gynecol Scand· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis